• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经德尔菲共识批准的屋尘螨过敏临床诊断问卷

Questionnaire for Clinical Diagnosis of House Dust Mite's Allergy Approved by Delphi Consensus.

作者信息

Tiotiu Angelica, Braido Fulvio, Kowal Krysztof, Fogelbach Guillermo Guidos, Neto Herberto Chong, Ivancevich Juan Carlos, Muti Daniela, Gonzalez-Barcala Francisco-Javier, Steiropoulos Paschalis, Novakova Silviya, Nedeva Denislava, Novakova Plamena, Mihaicuta Stefan, Bernstein Jonathan, Yorgancioglu Arzu, Santus Pierachille, Bikov Andras, Canonica Giorgio Walter, Pilette Charles

机构信息

Department of Pneumology, University Hospital Saint-Luc, 10 Avenue Hippocrate, 1200, Brussels, Belgium.

Pole Pneumology, ENT, and Dermatology - LUNS, Institute of Experimental and Clinical Research (IREC), UCLouvain, Brussels, Belgium.

出版信息

Clin Rev Allergy Immunol. 2025 Apr 30;68(1):45. doi: 10.1007/s12016-025-09055-0.

DOI:10.1007/s12016-025-09055-0
PMID:40304819
Abstract

Despite house dust mite (HDM)-allergy is the most frequent in the world, no standard questionnaire exists to help physicians in their clinical practice for screening patients with this possible diagnosis. The objective of this survey was to develop a questionnaire that could be used to identify patients with suspicion of HDM-allergy. The survey was conducted using the Delphi methodology. Nineteen international experts in allergology constituted the scientific board who established the items included in the first version of the questionnaire, defined the criteria of the selection for the next steps, and validated the final questionnaire and its interpretation. The initial version of the questionnaire included 15 items. For each item, five answers were suggested graduated by scores from "no importance" to "very high importance." The predefined conditions for the item selection after each round were a median score ≥ 7 and > 50% of responses according "high importance" and "very high importance." The electronic survey circulated within the Interasma Scientific Network platform. Eight questions based on the occurrence/worsening of symptoms induced by HDM-allergen exposure meet the survey criteria after the second and the third rounds and were included in the final questionnaire. Binomial answers for each question with 1 point accorded for "Yes" and none for "No" were suggested for the final version with a score ≥ 5 points associated with a high probability for HDM-allergy. By applying the Delphi process, we generated a brief questionnaire with binomial answers, easy to use in clinical practice for screening patients with HDM-allergy.

摘要

尽管屋尘螨(HDM)过敏是全球最常见的过敏症,但目前尚无标准问卷可帮助医生在临床实践中筛查可能患有这种疾病的患者。本次调查的目的是开发一种可用于识别疑似HDM过敏患者的问卷。该调查采用德尔菲法进行。19位国际过敏学专家组成了科学委员会,他们确定了问卷第一版中包含的项目,定义了后续步骤的选择标准,并验证了最终问卷及其解释。问卷的初始版本包含15个项目。对于每个项目,提供了五个答案,从“不重要”到“非常重要”按分数分级。每轮后项目选择的预定义条件是中位数得分≥7,且“高重要性”和“非常高重要性”的回答占比>50%。电子调查在Interasma科学网络平台内进行。经过第二轮和第三轮,基于HDM过敏原暴露引起的症状出现/加重的八个问题符合调查标准,并被纳入最终问卷。最终版本建议每个问题采用二项式答案,“是”得1分,“否”不得分,得分≥5分与HDM过敏的高概率相关。通过应用德尔菲法,我们生成了一份简短的二项式答案问卷,便于在临床实践中用于筛查HDM过敏患者。

相似文献

1
Questionnaire for Clinical Diagnosis of House Dust Mite's Allergy Approved by Delphi Consensus.经德尔菲共识批准的屋尘螨过敏临床诊断问卷
Clin Rev Allergy Immunol. 2025 Apr 30;68(1):45. doi: 10.1007/s12016-025-09055-0.
2
Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust.马来西亚办公室职员的哮喘、气道症状和鼻炎:与屋尘螨(HDM)过敏、猫过敏及办公室灰尘中屋尘螨过敏原水平的关联
PLoS One. 2015 Apr 29;10(4):e0124905. doi: 10.1371/journal.pone.0124905. eCollection 2015.
3
House dust mite allergy: The importance of house dust mite allergens for diagnosis and immunotherapy.尘螨过敏:尘螨变应原在诊断和免疫治疗中的重要性。
Mol Immunol. 2023 Jun;158:54-67. doi: 10.1016/j.molimm.2023.04.008. Epub 2023 Apr 27.
4
[Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].[标准化屋尘螨变应原皮下特异性免疫治疗对单一性和多发性变应性鼻炎患者的疗效比较及安全性分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Jun 6;56(6):774-783. doi: 10.3760/cma.j.cn112150-20220120-00071.
5
[Pitfalls in the diagnosis of house dust mite allergy].[屋尘螨过敏诊断中的陷阱]
HNO. 2024 Sep;72(9):619-625. doi: 10.1007/s00106-024-01425-y. Epub 2024 Feb 15.
6
Real-Life Study for the Diagnosis of House Dust Mite Allergy - The Value of Recombinant Allergen-Based IgE Serology.屋尘螨过敏诊断的真实生活研究——基于重组变应原的IgE血清学检测的价值
Int Arch Allergy Immunol. 2016;170(2):132-7. doi: 10.1159/000447694. Epub 2016 Aug 10.
7
A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens.一种低变应原性肽混合物,包含临床相关屋尘螨过敏原的 T 细胞表位。
Allergy. 2019 Dec;74(12):2461-2478. doi: 10.1111/all.13956. Epub 2019 Oct 3.
8
"A year-long, fortnightly, observational survey in three European countries of patients with respiratory allergies induced by house dust mites: Methodology, demographics and clinical characteristics".在三个欧洲国家针对屋尘螨诱发的呼吸道过敏患者开展的为期一年、每两周一次的观察性调查:方法、人口统计学及临床特征
BMC Pulm Med. 2016 May 23;16(1):85. doi: 10.1186/s12890-016-0246-9.
9
Hierarchy and molecular properties of house dust mite allergens.屋尘螨过敏原的分级和分子特性
Allergol Int. 2015 Oct;64(4):304-11. doi: 10.1016/j.alit.2015.05.004. Epub 2015 Jun 13.
10
Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.屋尘螨舌下变应原免疫治疗片剂治疗成人过敏性哮喘的疗效:一项随机临床试验。
JAMA. 2016 Apr 26;315(16):1715-25. doi: 10.1001/jama.2016.3964.

本文引用的文献

1
Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions.哮喘中的气道重塑:机制、诊断、治疗及未来方向
Arch Bronconeumol. 2025 Jan;61(1):31-40. doi: 10.1016/j.arbres.2024.09.007. Epub 2024 Sep 24.
2
Epithelial alarmins: a new target to treat chronic respiratory diseases.上皮警报素:治疗慢性呼吸道疾病的新靶点。
Expert Rev Respir Med. 2023 Jul-Dec;17(9):773-786. doi: 10.1080/17476348.2023.2262920. Epub 2023 Oct 27.
3
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus.
意大利重症哮喘网络关于重症哮喘临床缓解的定义:德尔菲共识
J Allergy Clin Immunol Pract. 2023 Dec;11(12):3629-3637. doi: 10.1016/j.jaip.2023.07.041. Epub 2023 Aug 7.
4
Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association survey.评估生物制剂治疗哮喘疗效的标准:全球哮喘协会调查
Expert Rev Respir Med. 2023 Jan-Jun;17(6):507-516. doi: 10.1080/17476348.2023.2223986. Epub 2023 Jun 26.
5
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.循证指南:嗜酸性肉芽肿性多血管炎的诊断与管理。
Nat Rev Rheumatol. 2023 Jun;19(6):378-393. doi: 10.1038/s41584-023-00958-w. Epub 2023 May 9.
6
House dust mite allergy: The importance of house dust mite allergens for diagnosis and immunotherapy.尘螨过敏:尘螨变应原在诊断和免疫治疗中的重要性。
Mol Immunol. 2023 Jun;158:54-67. doi: 10.1016/j.molimm.2023.04.008. Epub 2023 Apr 27.
7
[The impact of specialized management on allergic asthma outcomes].[专科管理对过敏性哮喘结局的影响]
Rev Mal Respir. 2023 Mar;40(3):209-221. doi: 10.1016/j.rmr.2023.01.011. Epub 2023 Feb 4.
8
Validated allergen exposure chamber is plausible tool for the assessment of house dust mite-triggered allergic rhinitis.经验证的过敏原暴露室是评估屋尘螨引发的过敏性鼻炎的合理工具。
Allergy. 2023 Jan;78(1):168-177. doi: 10.1111/all.15485. Epub 2022 Sep 1.
9
Response of upper and lower airway inflammation to bronchial challenge with house dust mite in Chinese asthmatics: a pilot study.中国哮喘患者上下气道炎症对屋尘螨支气管激发试验的反应:一项初步研究。
J Thorac Dis. 2021 Aug;13(8):4988-4998. doi: 10.21037/jtd-20-2876.
10
Preparing, conducting, and analyzing Delphi surveys: Cross-disciplinary practices, new directions, and advancements.准备、开展和分析德尔菲调查:跨学科实践、新方向与进展
MethodsX. 2021 May 28;8:101401. doi: 10.1016/j.mex.2021.101401. eCollection 2021.